Meridian Investment Counsel’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $235K | Hold |
2,725
| – | – | 0.05% | 227 |
|
|
2026
Q1 | $246K | Hold |
2,725
| – | – | 0.06% | 210 |
|
|
2025
Q4 | $245K | Sell |
2,725
-55
| -2% | -$5.21K | 0.06% | 213 |
|
|
2025
Q3 | $274K | Sell |
2,780
-145
| -5% | -$14.4K | 0.07% | 200 |
|
|
2025
Q2 | $267K | Hold |
2,925
| – | – | 0.07% | 199 |
|
|
2025
Q1 | $331K | Sell |
2,925
-100
| -3% | -$10.7K | 0.1% | 167 |
|
|
2024
Q4 | $320K | Hold |
3,025
| – | – | 0.1% | 172 |
|
|
2024
Q3 | $327K | Sell |
3,025
-123
| -4% | -$13.4K | 0.1% | 168 |
|
|
2024
Q2 | $342K | Hold |
3,148
| – | – | 0.11% | 165 |
|
|
2024
Q1 | $415K | Sell |
3,148
-250
| -7% | -$31.2K | 0.14% | 146 |
|
|
2023
Q4 | $414K | Hold |
3,398
| – | – | 0.14% | 146 |
|
|
2023
Q3 | $381K | Hold |
3,398
| – | – | 0.14% | 144 |
|
|
2023
Q2 | $495K | Hold |
3,398
| – | – | 0.18% | 123 |
|
|
2023
Q1 | $439K | Sell |
3,398
-200
| -6% | -$25.1K | 0.17% | 136 |
|
|
2022
Q4 | $459K | Hold |
3,598
| – | – | 0.18% | 125 |
|
|
2022
Q3 | $376K | Sell |
3,598
-12
| -0.3% | -$1.32K | 0.17% | 133 |
|
|
2022
Q2 | $379K | Hold |
3,610
| – | – | 0.16% | 137 |
|
|
2022
Q1 | $462K | Sell |
3,610
-108
| -3% | -$13K | 0.16% | 137 |
|
|
2021
Q4 | $459K | Sell |
3,718
-631
| -15% | -$82.6K | 0.15% | 137 |
|
|
2021
Q3 | $618K | Hold |
4,349
| – | – | 0.22% | 104 |
|
|
2021
Q2 | $679K | Hold |
4,349
| – | – | 0.24% | 103 |
|
|
2021
Q1 | $676K | Hold |
4,349
| – | – | 0.26% | 96 |
|
|
2020
Q4 | $651K | Sell |
4,349
-21
| -0.5% | -$2.97K | 0.27% | 89 |
|
|
2020
Q3 | $578K | Hold |
4,370
| – | – | 0.28% | 86 |
|
|
2020
Q2 | $506K | Hold |
4,370
| – | – | 0.26% | 93 |
|
|
2020
Q1 | $429K | Sell |
4,370
-155
| -3% | -$20.3K | 0.28% | 92 |
|
|
2019
Q4 | $658K | Sell |
4,525
-103
| -2% | -$14.2K | 0.33% | 81 |
|
|
2019
Q3 | $617K | Sell |
4,628
-7
| -0.2% | -$904 | 0.34% | 80 |
|
|
2019
Q2 | $530K | Buy |
4,635
+12
| +0.3% | +$1.41K | 0.29% | 88 |
|
|
2019
Q1 | $573K | Sell |
4,623
-51
| -1% | -$5.8K | 0.33% | 81 |
|
|
2018
Q4 | $471K | Hold |
4,674
| – | – | 0.31% | 87 |
|
|
2018
Q3 | $597K | Hold |
4,674
| – | – | 0.33% | 85 |
|
|
2018
Q2 | $506K | Hold |
4,674
| – | – | 0.29% | 94 |
|
|
2018
Q1 | $495K | Sell |
4,674
-52
| -1% | -$6.04K | 0.28% | 94 |
|
|
2017
Q4 | $554K | Hold |
4,726
| – | – | 0.3% | 89 |
|
|
2017
Q3 | $537K | Hold |
4,726
| – | – | 0.31% | 87 |
|
|
2017
Q2 | $589K | Hold |
4,726
| – | – | 0.35% | 77 |
|
|
2017
Q1 | $560K | Hold |
4,726
| – | – | 0.34% | 79 |
|
|
2016
Q4 | $473K | Sell |
4,726
-6
| -0.1% | -$643 | 0.32% | 90 |
|
|
2016
Q3 | $597K | Hold |
4,732
| – | – | 0.4% | 74 |
|
|
2016
Q2 | $553K | Sell |
4,732
-129
| -3% | -$14.6K | 0.38% | 78 |
|
|
2016
Q1 | $503K | Sell |
4,861
-51
| -1% | -$4.93K | 0.35% | 87 |
|
|
2015
Q4 | $489K | Sell |
4,912
-52
| -1% | -$5.09K | 0.36% | 81 |
|
|
2015
Q3 | $453K | Hold |
4,964
| – | – | 0.37% | 84 |
|
|
2015
Q2 | $526K | Hold |
4,964
| – | – | 0.38% | 81 |
|
|
2015
Q1 | $566K | Buy |
4,964
+7
| +0.1% | +$799 | 0.39% | 81 |
|
|
2014
Q4 | $546K | Hold |
4,957
| – | – | 0.4% | 81 |
|
|
2014
Q3 | $484K | Hold |
4,957
| – | – | 0.36% | 83 |
|
|
2014
Q2 | $500K | Buy |
4,957
+41
| +0.8% | +$4K | 0.39% | 85 |
|
|
2014
Q1 | $451K | Hold |
4,916
| – | – | 0.38% | 86 |
|
|
2013
Q4 | $445K | Buy |
+4,916
| New | +$425K | 0.38% | 88 |
|
Other funds holding ZBH
EIC
SCM
BTW
Meridian Investment Counsel's ZBH Position: Q2 2026 in Review
Meridian Investment Counsel held its Zimmer Biomet (ZBH) position steady in Q2 2026 at 2,725 shares worth $235K. The position accounts for 0.05% of the portfolio, ranked #227.
Meridian Investment Counsel first reported a position in ZBH in Q4 2013 and has held it in 51 quarters since. The position peaked at $679K in Q2 2021. 489 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.
- Meridian Investment Counsel held 2,725 shares of Zimmer Biomet worth $235K as of Q2 2026.
- Meridian Investment Counsel left its Zimmer Biomet share count unchanged in Q2 2026.
- Zimmer Biomet made up 0.05% of Meridian Investment Counsel's portfolio in Q2 2026, its #227 holding.
- Meridian Investment Counsel first reported a position in Zimmer Biomet in Q4 2013 and has held it in 51 quarters since.
- Meridian Investment Counsel's Zimmer Biomet position peaked at $679K in Q2 2021.
- 489 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.
Based on Meridian Investment Counsel's 13F filing for Q2 2026, filed 23 Jul 2026.